Insurers of private-credit firms are preparing for a wave of legal actions against boards and executives over disputed valuation practices [1].
This development signals a growing tension in the private-credit sector, where the lack of public market pricing often leads to disputes over the actual value of assets. As these disagreements move toward litigation, insurers face significant potential liabilities that could impact the stability of the broader credit market.
The legal focus is centered in London, which serves as the primary hub for Europe's private-credit market [2]. Legal practitioners in the city said the sector is becoming a dynamic frontier for litigation as the methods used to determine asset values are challenged in court [2].
Private-credit firms typically manage portfolios of loans to companies that are not traded on public exchanges. Because there is no daily ticker price, executives and boards must rely on internal models or third-party appraisals to set valuations. If these valuations are later found to be inflated or inaccurate, investors may sue the leadership for breach of fiduciary duty, or negligence [1].
Insurers are now bracing for this legal storm to protect their interests and manage the risk associated with directors and officers (D&O) insurance policies [1]. The surge in anticipated lawsuits suggests that the period of rapid growth in private credit may be entering a phase of increased scrutiny and regulatory pressure.
While the market has expanded quickly, the legal framework for resolving valuation disputes remains a critical point of contention. The outcome of these looming cases in London could set a precedent for how private assets are valued, and governed across the global financial system [2].
“Insurers are preparing for a wave of legal actions against private‑credit firm boards and executives over valuation practices.”
The shift toward litigation reflects a systemic risk in the private-credit boom: the 'valuation gap.' Without transparent, market-driven pricing, the industry relies on subjective assessments. If courts determine that these valuations were misleading, it could trigger a massive reallocation of risk toward insurers and force a standardization of valuation practices across the European and global credit markets.
